Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q2 EPS of ($1.51), $1.25 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.